
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter D - Drugs for Human Use
#### PART 320 - BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS
##### Subpart B - Procedures for Determining the Bioavailability or Bioequivalence of Drug Products
###### ยง 320.27 Guidelines on the design of a multiple-dose in vivo bioavailability study.
####### Achievement of steady-state conditions.

(c)Whenever a multiple-dose study is conducted, unless some other approach is more appropriate for valid scientific reasons, sufficient doses of the test product and reference material should be administered in accordance with the labeling to achieve steady-state conditions.
